Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May 1;132(5):e73.
doi: 10.1213/ANE.0000000000005353.

Neuromuscular Blocking Agents in the ICU: Why Work Blindfolded?

Affiliations
Comment

Neuromuscular Blocking Agents in the ICU: Why Work Blindfolded?

Giulio Luca Rosboch et al. Anesth Analg. .
No abstract available

PubMed Disclaimer

Comment in

  • In Response.
    Rezaiguia-Delclaux S, Stéphan F. Rezaiguia-Delclaux S, et al. Anesth Analg. 2021 May 1;132(5):e74. doi: 10.1213/ANE.0000000000005354. Anesth Analg. 2021. PMID: 33857990 No abstract available.

Comment on

References

    1. Rezaiguia-Delclaux S, Laverdure F, Genty T, et al. Neuromuscular blockade monitoring in acute respiratory distress syndrome: randomized controlled trial of clinical assessment alone or with peripheral nerve stimulation. Anesth Analg. 2021;132:1051–1059.
    1. Murray MJ, DeBlock H, Erstad B, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2016;44:2079–2103.
    1. Papazian L, Aubron C, Laurent Brochard L, et al. SDRA: Les recommandations de la SRLF. 2019. SRLF; Available at: https://www.srlf.org/rfe-srlf-prise-en-charge-du-syndrome-dedetresse-res... . Accessed October 4, 2020.
    1. deBacker J, Hart N, Fan E. Neuromuscular blockade in the 21st century management of the critically ill patient.Chest. 2017151697706
    1. Greenberg SB, Vender J. The use of neuromuscular blocking agents in the ICU: where are we now?Crit Care Med. 20134113321344

Substances

LinkOut - more resources